December 17, 2025. Data from multiple regions—including the UK, European Union, Japan, Canada, Australia, and the United States—indicate that feelings of loneliness intensify during the holidays, even though the period is culturally associated with togetherness and joy.
According to the OECD’s 2025 Social Connections and Loneliness Report, up to 14% of people in member countries report feeling lonely most or all of the time. In the United States, the American Psychological Association’s Stress in America 2025 survey found that roughly half of adults experience symptoms linked to loneliness, such as emotional detachment and social isolation.
Mental health experts argue that the holiday season amplifies emotional strain because it reinforces expectations that many people cannot meet.
“Holidays come with strong cultural narratives about happiness, closeness, and family unity,” said Dr. Hannah Nearney, a clinical psychiatrist and UK Medical Director at Flow Neuroscience. “When people are already struggling socially or emotionally, those expectations don’t disappear in December—they become more visible and more painful.”
Physical distance from family members and unresolved personal conflicts are among the most common contributors to holiday loneliness. This year, an estimated 14 million Americans will spend Christmas alone, nearly half of them due to strained relationships or geographic separation, according to figures from AMFM (A Mission for Michael). The OECD also notes a long-term decline in face-to-face interactions with friends and relatives over the past decade.
Seasonal traditions themselves can act as emotional triggers. “Christmas imagery—songs, films, rituals—activates memories and expectations around family,” explained Dr. Kultar Singh Garcha, NHS general practitioner and Chief Medical Officer at Flow Neuroscience. “If a loved one has died, relationships are fractured, or family members live far away, those cues can surface grief, anger, disappointment, and loneliness all at once.”
Stress, particularly financial pressure, further compounds the problem. A 2025 Festive Feeling study by the South African Depression and Anxiety Group found that more than one in three respondents reported unexplained fatigue and loneliness during the holiday period. OECD data also show that people facing unemployment or low income are nearly twice as likely to report chronic loneliness.
From a neurological perspective, stress can heighten social sensitivity. “High stress disrupts the prefrontal cortex, which governs emotional regulation and decision-making,” Dr. Nearney said. “When that control weakens, social interactions feel more threatening, and minor disconnections can seem overwhelming. Financial stress is especially powerful because it places the brain in survival mode, pushing social connection to the background.”
Clinicians emphasize that addressing holiday loneliness does not require meeting idealized social standards but instead focusing on manageable, meaningful forms of connection.
“Strengthen the relationships you already have, and don’t hesitate to set boundaries with difficult relatives,” said Dr. Garcha. “If meeting in person isn’t possible, regular video calls can still provide emotional continuity. Even small gestures—helping a stranger or offering a kind word—can reinforce a sense of belonging.”
Experts also advise seeking professional support when loneliness overlaps with persistent stress or low mood. Options range from psychotherapy and peer support groups to clinician-guided mental health tools.
Ultimately, rising holiday loneliness reflects a broader need to recalibrate expectations. Rather than striving to match an idealized version of festive happiness, clinicians say prioritizing personal well-being and realistic connection may be the most effective way to navigate the season.
About Flow Neuroscience
Flow Neuroscience is a healthcare company that focuses on tDCS therapies and devices. In 2016, it was co-founded in Sweden by Daniel Mansson, a clinical psychologist, and Erik Rehn, an engineer. Erin Lee joined as CEO in 2022, having previously worked at Google, Uber, and Babylon, and the company is now based in the UK. Flow is the only at-home medical tDCS device with clinically proven effectiveness in treating depression, approved in all major markets: by the American Food and Drug Administration (FDA), the UK’s National Health Service (NHS), the Australian Therapeutic Goods Administration (TGA), and having passed regulations in Europe, Norway, Switzerland, and Hong Kong.
